Drugmakers use nanotech to localize cancer treatment

02/24/2008 | Forbes

Drugmakers are exploring nanotechnology to produce new cancer treatments because of its ability to effectively target tumors while reducing damage to healthy tissues. Ortho Biotech Products LP, a Johnson & Johnson unit, has produced Doxil, a drug that uses liposome particles to localize treatment of myeloma and ovarian cancers, while Tempo Pharmaceuticals is devising a nanoscale delivery system designed to deliver two drugs to trap and target tumors from within.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations